Treatment of Zucker diabetic fatty rats with AVE7688 improves vascular and neural dysfunction

Aim: Vasopeptidase inhibitors are drugs that inhibit angiotensin‐converting enzyme and neutral endopeptidase (NEP). The latter is a protease that degrades vasoactive peptides and is increased in diabetes. We have previously shown that treating streptozotocin‐induced diabetic rats, an animal model of type 1 diabetes, with AVE7688, a vasopeptidase inhibitor, improves neurovascular and neural function. In this study, we determined the effect of...